SPONGIT: Comparison of Two Surgical Approaches in the Treatment of Degenerative Spondylolysthesis

Sponsor
University Hospital, Bordeaux (Other)
Overall Status
Completed
CT.gov ID
NCT00869882
Collaborator
(none)
60
1
2
53
1.1

Study Details

Study Description

Brief Summary

This trial, conducted in adult patients with degenerative spondylolisthesis needing surgical treatment at one level, aimed at comparing two approaches of spinal fusion.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Circumferential arthrodesis
  • Procedure: Posterolateral fusion with instrumentation
N/A

Detailed Description

Degenerative spondylolisthesis is defined as the slip of one vertebra onto the other due to degenerative lesions; the L4-L5 intervertebral space is mainly involved. Mean age of symptomatic disease is about 60. Surgery is indicated in the presence of radiculalgia and/or neurological claudication and/or invalidating lombalgia, worsening neurological deficit, presence of sphincterian incontinence.

Surgical treatment of degenerative spondylolisthesis usually consists in neural decompression followed by posterolateral fusion with instrumentation. In the literature, fusion rate is estimated to be 80% with GPLI and seems to be increased by interbody fusion, especially transforaminal lumbar interbody fusion which has the advantage of unilateral disc interspace route, and fusion rate over 90%.

It seems that hypolordosis in the instrumented segments caused increased loading of the posterior column in the adjacent segments. These biomechanical effects may explain the degenerative changes at the junction level that have been observed as long-term consequences of lumbar fusion.

In addition to fusion, segmental lordosis gain seems to be an important long-term prognostic factor. Segmental lordosis recovery (upper than 3° in order to take into account measurement variability), was never assessed after TLIF procedure nor compared to that after posterolateral fusion in controlled randomized clinical trials.

The main objective of the study is the comparison of efficacy between circumferential fusion (TLIF plus GPLI) and GPLI alone as surgical treatment of degenerative spondylolisthesis in term of "Success" rate, defined as fusion and at least 3-degree increase of segmental lordosis angle, 24 months after surgery.

In this trial, included patients will be randomly assigned to undergo either posterolateral fusion with instrumentation (GPLI) or circumferential fusion with transforaminal lumbar interbody fusion (TLIF) combined to GPLI. In both arms, bone autograft will be performed using loose fragments obtained during neurological decompression.

Six visits are planned during the study: pre-inclusion visit within 3 months before surgery, inclusion/randomisation on the day before surgery, 3 follow-up visits (2, 6, and 12 months after surgery) and an end of study visit 24 months after surgery (or at time of withdrawal if relevant). Hospital stay (about one week, on average) is planned after surgery.

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparison of 2 Surgical Approaches in the Treatment of Degenerative Spondylolysthesis: Posterolateral Fusion With Instrumentation (GPLI) Plus or Minus Transforaminal Lumbar Interbody Fusion (TLIF)
Study Start Date :
Jun 1, 2009
Actual Primary Completion Date :
Nov 1, 2013
Actual Study Completion Date :
Nov 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

Posterolateral fusion with instrumentation combined to transforaminal lumbar interbody fusion

Procedure: Circumferential arthrodesis
Patients are carefully positioned in the proned position and submitted to a posterior surgical approach under general anaesthesia. Surgical levels are viewed laterally by mean of intraoperative radiographs which can be performed at surgeon's demand during the whole surgery time. The preceding procedure is performed. In case of foraminal stenosis, decompression is performed at the same time as discal approach via the narrowest foramen. In addition to this, before preparation of bed for bone grafting, nerve roots are retracted and the disc nucleus is removed entirely, then endplate decortication is performed. The disc space is distracted. The most anterior part of the disc space is packed with cancellous bone. A cage packed with bone is inserted into the anterior portion of the interspace. According to cage location, bone graft could be inserted in the posterior portion of the interspace. Cage placement is radiologically checked. The end of the procedure is the same as for GPLI.
Other Names:
  • TLIF+GPLI
  • Active Comparator: 2

    Posterolateral fusion with instrumentation

    Procedure: Posterolateral fusion with instrumentation
    Patients are carefully positioned in pronation and submitted to a posterior surgical approach under general anaesthesia. Surgical levels are viewed laterally by mean of intraoperative radiographs performed at surgeon's demand during the whole surgery time. Pedicle screw instrumentation is performed, followed by posterior neural decompression depending on the type of stenosis: Central stenosis: decompression is performed including medial facectomy, laminectomy; Foraminal stenosis: foraminotomy is performed, while preserving a graft bed as large as possible; Pure foraminal stenosis: spinal duct is not opened. Local bone is harvested from the lamina and the spinous process and carefully fragmented for autologous graft. Subperiosteal dissection is performed between the transverse processes and lateral aspects of the facet joints. Two rods are placed and locked on screws in maximum compression to optimize segmental lordosis. Bone autograft is placed into this bed.
    Other Names:
  • GPLI
  • Outcome Measures

    Primary Outcome Measures

    1. Success rate defined as fusion associated to at least a 3-degree increase of segmental lordosis angle and the absence of a reintervention due to a failure of the initial intervention [24 months after surgery]

    Secondary Outcome Measures

    1. Major complication (ie, life threatening haemorrhage, severe and persisting neurological worsening, deep infection) rate, and minor complication rate [within 24 months after surgery]

    2. Success rate defined as both fusion and at least 3-degree increase of segmental lordosis angle [6 and 12 months after surgery]

    3. Lumbar and radicular pain outcome [2, 6, 12 and 24 months after surgery]

    4. Functional outcome: Oswestry Disability Index and modified Prolo Economic and Functional scores [2, 6, 12 and 24 months after surgery]

    5. Change of pelvic and radiological parameters (ie, lumbar lordosis angle, medial intervertebral space height [2, 6, 12 and 24 months after surgery]

    6. Quality of life outcome: SF-36 [2, 6, 12 and 24 months after surgery]

    7. Per and post operative surgery parameters (ie, operative time, blood loss, hospitalization stay duration) [within hospital stay due to surgery]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 74 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Adults aged less than 75,

    • Having been informed about clinical trial objectives and risk,

    • Covered by health insurance system,

    • Suffering from degenerative spondylolisthesis (whatever the grade and intervertebral disc height) needing one-level surgical fusion due to either invalidating lombalgia/radiculalgia despite 6-month optimal medical treatment and/or motor neurological symptoms.

    Exclusion Criteria:
    • Previous lumbar fusion,

    • Previous spine traumatism,

    • Presence of at least one major contraindication to surgery and/or general anaesthesia (ie, non controlled coagulopathy, active infection, or serious underlying disease, auto-immune affection).

    • Presence of at least one contraindication to either TLIF or GPLI,

    • Severe radiological osteoporosis.

    • Active cancer at time of inclusion into the study.

    • Unlikely to comply with the requirements of the study and/or to complete the study for psychological, social, familial or geographical reasons.

    • Under any administrative or legal supervision.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Service de chirurgie orthopédique, Hôpital Pellegrin Tripode Bordeaux France 33076

    Sponsors and Collaborators

    • University Hospital, Bordeaux

    Investigators

    • Principal Investigator: Patrick GUERIN, MD, University Hospital Bordeaux, France
    • Study Chair: Antoine BENARD, MD, University Hospital Bordeaux, France

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    University Hospital, Bordeaux
    ClinicalTrials.gov Identifier:
    NCT00869882
    Other Study ID Numbers:
    • CHUBX 2008/33
    First Posted:
    Mar 26, 2009
    Last Update Posted:
    Oct 30, 2014
    Last Verified:
    Oct 1, 2014
    Keywords provided by University Hospital, Bordeaux
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 30, 2014